Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2002
10/17/2002WO2002080887A2 Timed pulse release composition
10/17/2002WO2002080857A2 Polymorphs of fexofenadine hydrochloride
10/17/2002WO2002080663A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages
10/17/2002WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002WO2002062260A3 Improved ophthalmic and contact lens solutions containing forms of vitamin b
10/17/2002WO2002054851A3 Inhibition of pathological angiogenesis in vivo
10/17/2002WO2002047493A3 Health promoting compositions
10/17/2002WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002WO2002034726A3 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/17/2002WO2002029061A3 G-protein coupled receptors
10/17/2002WO2002010192A9 Somatostatin analogues
10/17/2002WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002WO2001098323A3 G-protein coupled receptors
10/17/2002WO2001081551A3 Retinal pigment epithelial cell lines with extended life-span and their applications
10/17/2002WO2001057015A9 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION
10/17/2002WO2001052878A9 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
10/17/2002WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002US20020151588 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side effects
10/17/2002US20020151573 Anticancer agents
10/17/2002US20020151547 Substituted phenyl-piperidine methanone compounds
10/17/2002US20020151499 Using histacalin protein isolated from ticks
10/17/2002US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002US20020151472 Trefoil factor (TFF) peptides (tricyclic peptides, e.g., TFF2 peptides), for increasing the viscosity of mucus layers; used for treating damaged or abnormal mucus layers, e.g. in the gastrointestinal tract, respiratory/urogential systems, eyes
10/17/2002US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002US20020150638 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/17/2002US20020150574 Cancer diagnosis, therapy; Dna vaccine
10/17/2002DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002CA2444456A1 Polymorphs of fexofenadine hydrochloride
10/17/2002CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002CA2443378A1 Methods of screening and using inhibitors of angiogenesis
10/17/2002CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002CA2441638A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages
10/17/2002CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/16/2002EP1249234A1 Method of preventing retinopathy of prematurity in a neonate
10/16/2002EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002EP1248847A1 Irak-4: compositions and methods of use
10/16/2002EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002EP1248643A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
10/16/2002EP1248630A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
10/16/2002EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
10/16/2002EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002EP1248517A2 Clonal propagation of primate offspring by embryo splitting
10/16/2002EP1210094A4 Herbal compositions and uses for the treatment of allergic reactions
10/16/2002EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/16/2002EP0941108B1 Wound healing and treatment of fibrosis
10/16/2002EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002EP0641203B1 Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists
10/16/2002CN1374967A Compounds for the treatment of ischemia
10/16/2002CN1374966A 嘌呤衍生物 Purine derivatives
10/16/2002CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives
10/16/2002CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002CN1374873A Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions
10/16/2002CN1374860A Utilization of a highly fluorinated oligomeric alkan in ophthalmology
10/16/2002CN1374085A Externally used and ophthalmic gel prepn of levo ofloxacin
10/16/2002CN1092652C 2-imidazolinylaminoindole compound and composition containing the same use
10/16/2002CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/15/2002US6465687 Thyroid receptor ligands and method
10/15/2002US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465464 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
10/15/2002US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002US6464990 Nanoemulsion based on ethylene oxide and propylene oxide block copolymers and its uses in the cosmetics, dermatological and/or ophthalmological fields
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/15/2002CA1341393C Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
10/10/2002WO2002079506A1 Determination of risk factors for cataract by aldose reductase genotype
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079235A2 Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
10/10/2002WO2002079221A2 Sapogenin derivatives, their synthesis and use
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002WO2002079170A2 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079165A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078713A1 Remedies for retina and choroid diseases containing steroids as the active ingredient
10/10/2002WO2002078705A1 Hsp inductor
10/10/2002WO2002078699A1 Compounds and methods
10/10/2002WO2002078697A1 Compounds and methods
10/10/2002WO2002078696A1 Compounds and methods
10/10/2002WO2002078681A2 Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
10/10/2002WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002WO2002078564A2 Method for creating a separation of posterior cortical vitreous from the retina of the eye
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002058636A3 Novel cannabimimetic ligands
10/10/2002WO2002046373A8 Method of collecting placental stem cells
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002004612A3 Drug metabolizing enzymes